These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11286536)

  • 1. Gene therapy for tolerance and autoimmunity: soon to be fulfilled promises?
    El-Amine M; Melo ME; Scott DW
    Clin Immunol; 2001 Apr; 99(1):1-6. PubMed ID: 11286536
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation-induced cell death in T cells and autoimmunity.
    Zhang J; Xu X; Liu Y
    Cell Mol Immunol; 2004 Jun; 1(3):186-92. PubMed ID: 16219166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
    Chen W; Ford MS; Young KJ; Zhang L
    Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease.
    Alderuccio F; Chan J; Scott DW; Toh BH
    Trends Mol Med; 2009 Aug; 15(8):344-51. PubMed ID: 19665432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas ligand--a double-edged sword.
    Chen Y; Wilson JM
    Nat Biotechnol; 1998 Nov; 16(11):1011-2. PubMed ID: 9831025
    [No Abstract]   [Full Text] [Related]  

  • 7. [Autoimmune diseases and cytokines].
    Akahoshi T
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):936-41. PubMed ID: 8753063
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoimmunity and lymphoproliferation: two genes are worse than one.
    Cohen PL
    Mol Interv; 2002 Nov; 2(7):427-30. PubMed ID: 14993405
    [No Abstract]   [Full Text] [Related]  

  • 9. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice.
    Cortes-Hernandez J; Fossati-Jimack L; Petry F; Loos M; Izui S; Walport MJ; Cook HT; Botto M
    Eur J Immunol; 2004 Dec; 34(12):3713-22. PubMed ID: 15517607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells engineered to express Fas ligand suppress pre-sensitized antigen-specific T cell responses in vivo.
    Kosiewicz MM; Krishnan A; Worthington MT; Matriano JA; Ross WG
    Eur J Immunol; 2002 Jun; 32(6):1679-87. PubMed ID: 12115651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [T-cell tolerance and autoimmunity].
    Kamradt T; Hansen G; Bechmann I; Burmester GR
    Internist (Berl); 2003 Feb; 44(2):146-52. PubMed ID: 12674734
    [No Abstract]   [Full Text] [Related]  

  • 12. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death.
    Muppidi JR; Siegel RM
    Nat Immunol; 2004 Feb; 5(2):182-9. PubMed ID: 14745445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas/FasL interaction: a novel immune therapy approach with immobilized biologicals.
    Scholz M; Cinatl J
    Med Res Rev; 2005 May; 25(3):331-42. PubMed ID: 15599929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells.
    Setterblad N; Blancheteau V; Delaguillaumie A; Michel F; Bécart S; Lombardi G; Acuto O; Charron D; Mooney N
    J Leukoc Biol; 2004 Jun; 75(6):1036-44. PubMed ID: 14982950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Fas ligand in immune privilege.
    Green DR; Ferguson TA
    Nat Rev Mol Cell Biol; 2001 Dec; 2(12):917-24. PubMed ID: 11733771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective T cell activation and autoimmune disorder in Stra13-deficient mice.
    Sun H; Lu B; Li RQ; Flavell RA; Taneja R
    Nat Immunol; 2001 Nov; 2(11):1040-7. PubMed ID: 11668339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of Fas/FasL in tuberculosis].
    Liu JH; Wang YN; Zhang CL
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):783-6. PubMed ID: 15634397
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation-induced apoptosis and cell surface expression of Fas (CD95) ligand are reciprocally regulated by retinoic acid receptor alpha and gamma and involve nur77 in T cells.
    Tóth R; Szegezdi E; Reichert U; Bernardon JM; Michel S; Ancian P; Kis-Tóth K; Macsári Z; Fésüs L; Szondy Z
    Eur J Immunol; 2001 May; 31(5):1382-91. PubMed ID: 11465095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpressed exogenous IL-4 And IL-10 paradoxically regulate allogenic T-cell and cardiac myocytes apoptosis through FAS/FASL pathway.
    Furukawa H; Oshima K; Tung T; Cui G; Laks H; Sen L
    Transplantation; 2008 Feb; 85(3):437-46. PubMed ID: 18301335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.